Filing Details
- Accession Number:
- 0001968202-24-000066
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-02-16 16:15:32
- Reporting Period:
- 2024-02-14
- Accepted Time:
- 2024-02-16 16:15:32
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 872589 | Regeneron Pharmaceuticals Inc. | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1411984 | P Daniel Plew Van | 777 Old Saw Mill River Road Tarrytown NY 10591 | Evp & General Mgr, Industrial | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-02-14 | 439 | $937.94 | 30,373 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-02-14 | 226 | $938.13 | 30,147 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-02-14 | 750 | $939.60 | 29,397 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-02-14 | 4,261 | $940.44 | 25,136 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-02-14 | 275 | $941.41 | 24,861 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-02-14 | 2,691 | $943.51 | 22,170 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-02-14 | 620 | $944.30 | 21,550 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-02-14 | 95 | $945.81 | 21,455 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-02-14 | 240 | $947.81 | 21,215 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-02-14 | 150 | $948.70 | 21,065 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-02-14 | 112 | $949.07 | 20,953 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-02-14 | 375 | $950.45 | 20,578 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-02-14 | 200 | $951.77 | 20,378 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 12,376 | Indirect | 2023 GRAT |
| Common Stock | 1,084 | Indirect | By 401(k) Plan |
Footnotes
- Represents volume-weighted average price of sales of 439 shares of Company stock on February 14, 2024 at prices ranging from $937.86 to $937.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price.
- Represents volume-weighted average price of sales of 226 shares of Company stock on February 14, 2024 at prices ranging from $938.00 to $938.45. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price.
- Represents volume-weighted average price of sales of 750 shares of Company stock on February 14, 2024 at prices ranging from $939.39 to $939.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price.
- Represents volume-weighted average price of sales of 4,261 shares of Company stock on February 14, 2024 at prices ranging from $940.06 to $940.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price.
- Represents volume-weighted average price of sales of 275 shares of Company stock on February 14, 2024 at prices ranging from $941.09 to $941.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price.
- Represents volume-weighted average price of sales of 2,691 shares of Company stock on February 14, 2024 at prices ranging from $943.23 to $943.82. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price.
- Represents volume-weighted average price of sales of 620 shares of Company stock on February 14, 2024 at prices ranging from $944.29 to $944.30. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price.
- Represents volume-weighted average price of sales of 95 shares of Company stock on February 14, 2024 at prices ranging from $945.66 to $945.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price.
- Represents volume-weighted average price of sales of 240 shares of Company stock on February 14, 2024 at prices ranging from $947.77 to $947.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price.
- Represents volume-weighted average price of sales of 150 shares of Company stock on February 14, 2024 at prices ranging from $948.13 to $948.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price.
- Represents volume-weighted average price of sales of 112 shares of Company stock on February 14, 2024 at prices ranging from $949.02 to $949.14. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price.
- Represents volume-weighted average price of sales of 375 shares of Company stock on February 14, 2024 at prices ranging from $950.37 to $950.55. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price.
- Represents volume-weighted average price of sales of 200 shares of Company stock on February 14, 2024 at prices ranging from $951.61 to $951.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price.
Billionaire Hedge Funds
